Abstract:Erythropoietin-producing hepatocellular carcinoma cell surface type-A receptor 3 (EPHA3) has been found to promote the proliferation and survival of prostate cancer (PCa) cell lines and prostate tumor development in nude mice. However, the regulation of EPHA3 in PCa remains largely unknown. This study is aimed to investigate the association between EPHA3 expression and androgen receptor (AR) signaling and the potential mechanism. We determined mRNA and protein levels of EPHA3 and AR signaling-related genes in the PCa cell line 22Rv1 by reverse transcription-polymerase chain reaction (RT-PCR) and western blotting, respectively. The EPHA3 mRNA and protein levels were both found to be elevated by dihydrotestosterone (DHT) hormone in a dose- and time-dependent manner, as AR and prostate-specific antigen (PSA) expression were increased. Similarly, EPHA3 protein levels were also increased in the PCa cell line LNCaP stimulated with DHT or mibolerone (Mib). Overexpression of pEGFP-AR in 22Rv1 cells significantly increased the EphA3 level, while AR knockdown with small interfering RNA (siRNA) for AR (siAR) markedly decreased the expression of EPHA3. The key EPHA3 promoter region associated with AR regulation was evaluated by co-transfection of various pGL3-basic-luciferase reporter plasmids, containing EPHA3 core promoter fragments differing in length, with the AR plasmid or siAR into 22Rv1 cells. AR overexpression in 22Rvl cells raised the EphA3 promoter transcription activity of pGL3-EPHA3-Luc (EPHA3-Luc)-789, and vice versa. Similarly, luciferase activity of EPHA3-Luc-317 was also clearly affected. However, truncated EPHA3-Luc-237 without the transcription factor specific protein 1 (SP1) binding sites or EPHA3-Luc-789SP1 with modified SP1 binding sites clearly decreased EPHA3 promoter activity regardless of whether AR was overexpressed or blocked. Treatment of 22Rv1 cells with 10 and 100 nM of the SP1 inhibitor mithramycin A for 24 and 48 h significantly reduced EPHA3 mRNA and protein levels. Additionally, selective inhibition of SP1 with siRNA SP1 (siSP1) at various concentration from 25 to 75 nM, reduced the EPHA3 protein level in PCa LNCaP cells, accordingly. Co-immunoprecipitation (co-IP) and chromatin IP (ChIP) assays were performed to determine whether AR forms a transcription factor complex with Sp1 that binds the EPHA3 core promoter region to sense androgen induction. The result suggests that the interaction of AR and SP1 contributes to regulate EPHA3 expression, and the SP1 binding sites (-295 similar to-261) in the EPHA3 core promoter region is crucial to the regulation of EPHA3 expression in response to androgen hormone stimuli.

Identification of SRC3/AIB1 as a Preferred Coactivator for Hormone-activated Androgen Receptor

Androgen receptor cofactors: A potential role in understanding prostate cancer

SRC-3, a Steroid Receptor Coactivator: Implication in Cancer

SRC-3 Has a Role in Cancer Other Than As a Nuclear Receptor Coactivator

Correction: Functional Domain and Motif Analyses of Androgen Receptor Coregulator ARA70 and Its Differential Expression in Prostate Cancer.

Data from the Steroid Receptor Coactivator-3 is Required for the Development of Castration-Resistant Prostate Cancer

The role of SRC-1 in murine prostate cancinogenesis is nonessential due to a possible compensation of SRC-3/AIB1 overexpression

Identification and Characterization of a Novel Androgen Receptor Coregulator ARA267-α in Prostate Cancer Cells

Differential Gene Regulation by the SRC Family of Coactivators.

Canonical androgen response element motifs are tumor suppressive regulatory elements in the prostate

ACTR/AIB1/SRC-3 and androgen receptor control prostate cancer cell proliferation and tumor growth through direct control of cell cycle genes

Mapping the androgen receptor cistrome reveals a novel program controlling the growth of androgen-independent prostate cancer

Integrated Expression Profiling And Chip-Seq Analyses Of The Growth Inhibition Response Program Of The Androgen Receptor

Abstract 6282: Novel androgen related gene network in prostate cancer cell model

Regulatory Mechanism of Androgen Receptor on NCAPD3 Gene Expression in Prostate Cancer.

Androgen Receptor Induces EPHA3 Expression by Interacting with Transcription Factor SP1

Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer

The MYH9 Cytoskeletal Protein is a Novel Corepressor of Androgen Receptors

Molecular Dynamics Simulations Revealed the Regulation of Ligands to the Interactions between Androgen Receptor and Its Coactivator

AN S296R MUTATION IN THE HUMAN ANDROGEN RECEPTOR CAUSES ACTIVATION OF THE RECEPTOR BY NON‐ANDROGENIC STEROIDS AND STRONGER INHIBITION BY THE NUCLEAR RECEPTOR COREPRESSOR N‐coR

Interactions Between Activating Signal Cointegrator-2 And The Tumor Suppressor Retinoblastoma In Androgen Receptor Transactivation